SCHEMBL16089516

SCHEMBL16089516

CNO/C(C)=C/c1ncnc(N)c1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16091227 0.83 TKT (0.32) —
SCHEMBL16090189 0.72 NOS2 (0.32) —
SCHEMBL16089515 0.72 — —
SCHEMBL17622758 0.71 CYP1A2 (0.33) —
SCHEMBL17623469 0.69 CHEK1 (0.30) —
SCHEMBL17623157 0.68 KDR (0.31) —
SCHEMBL17623004 0.67 MAPK13 (0.32) —
SCHEMBL16091376 0.67 KDM4E (0.32) —
SCHEMBL16091155 0.66 CYP1A2 (0.36) —
SCHEMBL16091488 0.65 ACACB (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014144169-A1 CARM1 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-09-18 — — WO disclosed
Send feedback